HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Streit, J. A. Articles by Wilson, M. E. Search for Related Content PubMed PubMed Citation Articles by Streit, J. A. Articles by Wilson, M. E.

Protective Immunity Against the Protozoan Leishmania chagasi Is Induced by Subclinical Cutaneous Infection with Virulent But Not Avirulent Organisms¹

Judy A. Streit^2,*,, Thomas J. Recker^*, Frederico Gueiros Filho, Stephen M. Beverley^¶ and Mary E. Wilson^*,,

Departments of ^* Internal Medicine and Microbiology, University of Iowa and the Veterans Affairs Medical Center, Iowa City, IA 52242; Department of Molecular and Cellular Biology, Harvard University, Cambridge, MA 02115; and the ^¶ Department of Molecular Microbiology, Washington University, St. Louis, MO 63110

Protective immunity against Leishmania major is provided by s.c. immunization with a low dose of L. major promastigotes or with dihydrofolate-thymidylate synthase gene locus (DHFR-TS) gene knockout L. major organisms. Whether these vaccine strategies will protect against infection with other Leishmania species that elicit distinct immune responses and clinical syndromes is not known. Therefore, we investigated protective immunity to Leishmania chagasi, a cause of visceral leishmaniasis. In contrast to L. major, a high dose s.c. inoculum of L. chagasi promastigotes was required to elicit protective immunity. Splenocytes from mice immunized with a high dose produced significantly greater amounts of IFN- and lower TGF- than mice immunized with a low dose of promastigotes. The development of protective immunity did not require the presence of NK cells. Protection was not afforded by s.c. immunization with either attenuated L. chagasi or with L. major promastigotes, and s.c. L. chagasi did not protect against infection with L. major. Subcutaneous immunization with DHFR-TS gene knockouts derived from L. chagasi, L. donovani, or L. major did not protect against L. chagasi infection. We conclude that s.c. inoculation of high doses of live L. chagasi causes a subclinical infection that elicits protective immune responses in susceptible mice. However, L. chagasi that have been attenuated either by long-term passage or during the raising of recombinant gene knockout organisms do not elicit protective immunity, either because they fail to establish a subclinical infection or because they no longer express critical antigenic epitopes.

This article has been cited by other articles:

				D. R. A. Martins, S. M. B. Jeronimo, J. E. Donelson, and M. E. Wilson Leishmania chagasi T-Cell Antigens Identified through a Double Library Screen Infect. Immun., December 1, 2006; 74(12): 6940 - 6948. [Abstract] [Full Text] [PDF]

				M. T. M. Roberts Current understandings on the immunology of leishmaniasis and recent developments in prevention and treatment Br. Med. Bull., July 17, 2006; 75-76(1): 115 - 130. [Abstract] [Full Text] [PDF]

				S. Ahmed, M. Colmenares, L. Soong, K. Goldsmith-Pestana, L. Munstermann, R. Molina, and D. McMahon-Pratt Intradermal Infection Model for Pathogenesis and Vaccine Studies of Murine Visceral Leishmaniasis Infect. Immun., January 1, 2003; 71(1): 401 - 410. [Abstract] [Full Text] [PDF]

				Y. B. Achour, M. Chenik, H. Louzir, and K. Dellagi Identification of a Disulfide Isomerase Protein of Leishmania major as a Putative Virulence Factor Infect. Immun., July 1, 2002; 70(7): 3576 - 3585. [Abstract] [Full Text] [PDF]